KPT-185

CAS No. 1333151-73-7

KPT-185( —— )

Catalog No. M11326 CAS No. 1333151-73-7

KPT-185 is a selective CRM1 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 43 In Stock
10MG 59 In Stock
25MG 96 In Stock
50MG 162 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    KPT-185
  • Note
    Research use only, not for human use.
  • Brief Description
    KPT-185 is a selective CRM1 inhibitor.
  • Description
    KPT-185 is a selective CRM1 inhibitor.
  • In Vitro
    Cell Viability Assay Cell Line:HPB-ALL, Jurkat, CCRF-CEM, MOLT-4, KOPTK1, LOUCY cells Concentration:1, 10, 100, 1000 nM Incubation Time:72 hours Result:The growth of those lines was dramatically reduced with IC50s of 16–395 nM after 72 h of exposure.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    CRM1
  • Recptor
    CRM1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1333151-73-7
  • Formula Weight
    355.31
  • Molecular Formula
    C16H16F3N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 71 mg/mL (199.82 mM); DMSO: 71 mg/mL (199.82 mM)
  • SMILES
    CC(C)OC(=O)/C=C\N1C=NC(=N1)C2=CC(=CC(=C2)OC)C(F)(F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ranganathan P, et al. Blood. 2012, 120(9), 1765-1773.
molnova catalog
related products
  • KPT-185

    KPT-185 is a selective CRM1 inhibitor.

  • KPT276

    KPT-276 is an orally bioavailable selective inhibitor of nuclear export (SINE) that irreversibly bind to CRM1 and block the function of CRM1.

  • KPT-330

    KPT-330 inhibited proliferation and induced cell cycle arrest and apoptosis-related proteins in 11 NSCLC cells lines.